Recent Comments

Comment RSS

Vitamin K News and Research RSS Feed - Vitamin K News and Research

Vitamin K is a nutrient that the body needs in small amounts to function and stay healthy. Vitamin K helps to form blood clots (a mass that forms when blood platelets, proteins, and cells stick together) and maintain strong bones. It is fat-soluble (can dissolve in fats and oils) and is found in green leafy vegetables, broccoli, liver, and vegetable oils. Vitamin K is also made by bacteria that live in the large intestine. Not enough vitamin K can lead to bleeding and bruising. It is a type of phylloquinone.

Pfizer’s Revatio Injection receives FDA approval

20. November 2009 09:18
Pfizer announced today that the U.S. Food and Drug Administration (FDA) has approved Revatio® (sildenafil) Injection, an intravenous formulation of Revatio. Revatio is the only FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations. [More]

Global demand for nutraceutical ingredients to reach $21.8 billion in 2013

11. November 2009 06:23
Demand for nutraceutical ingredients worldwide is projected to advance 6.2 percent annually to $21.8 billion in 2013, serving a $236 billion global nutritional product industry. [More]

FDA approves Daiichi Sankyo's sNDA for Welchol

7. October 2009 09:04
Daiichi Sankyo, Inc. (DSI) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Welchol® (colesevelam HCl) to be used as an adjunct to diet and exercise for the reduction of elevated low-density lipoprotein cholesterol (LDL-C) in boys and postmenarchal girls, 10 to 17 years of age, with heterozygous familial hypercholesterolemia (heFH) alone or in combination with a statin after failing an adequate trial of diet therapy. [More]

The Top 10 Medical Innovations for 2010 announced at Cleveland Clinic Medical Innovation Summit

7. October 2009 07:50
Cleveland Clinic's Top 10 Medical Innovations for 2010 list features a wide range of new techniques and therapies that are being developed to treat everything from deafness and Parkinson's disease to pneumonia and sleep disorders. [More]

Vitamin K prevents age-related conditions

18. September 2009 01:54
An important analysis conducted by Children's Hospital Oakland Research Institute scientists suggests the importance of ensuring optimal dietary intakes of vitamin K to prevent age-related conditions such as bone fragility, arterial and kidney calcification, cardiovascular disease, and possibly cancer. Vitamin K is concentrated in dark green plants such as spinach or Swiss chard, and is either not present or present in only small amounts in most multivitamin pills. [More]

Turmeric spice and vitamin D may help clear amyloid plaques found in Alzheimer's

15. July 2009 19:58
UCLA scientists and colleagues from UC Riverside and the Human BioMolecular Research Institute have found that a form of vitamin D, together with a chemical found in turmeric spice called curcumin, may help stimulate the immune system to clear the brain of amyloid beta, which forms the plaques considered the hallmark of Alzheimer's disease. [More]

Posted in: Medical Research News

Tags: , , , ,

Flavonoids offer dementia, Alzheimer's hope

12. July 2009 19:04
A group of chemicals found in many fruits and vegetables, as well as tea, cocoa and red wine, could protect the brain from Alzheimer's disease, a dementia expert told scientists at a conference last Friday. [More]

Embryonic stem cells used to create human sperm

9. July 2009 16:33
Human sperm have been created using embryonic stem cells for the first time in a scientific development which will lead researchers to a better understanding of the causes of infertility. [More]

A new prostate cancer "homing device" for drug delivery

6. July 2009 20:23
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds and penetrates prostate cancer cells and has created imaging agents and therapeutic drugs that can link to the molecule and be carried with it as cargo. [More]

Posted in: Men's Health News | Medical Research News

Tags: , , , ,

FDA approves Alimta (pemetrexed) for advanced lung cancer

6. July 2009 19:35
The U.S. Food and Drug Administration has approved Alimta (pemetrexed), the first drug available for maintenance therapy of advanced or metastatic lung cancer. [More]

Drink milk to lose weight!

2. July 2009 19:33
According to the latest research milk helps satisfy hunger by making people feel full and could be useful in weight loss. [More]

Posted in: Medical Research News

Tags: , , ,

Vitamin A supplements can reduce malaria cases in children by one-third, study finds

29. June 2009 03:02
In malaria-endemic areas, vitamin A supplements - which cost about 2 U.S. cents each - can help reduce infections in children by one-third, according to a study published in the Malaria Journal, IRIN reports. [More]

Posted in: Child Health News | Disease/Infection News

Tags: , , , ,

Women warned not to wait too long to have a baby

21. June 2009 23:31
Women are being warned that they should consider starting a family before the age of 35 or they will risk missing out on motherhood. [More]

Posted in: Women's Health News

Tags: , , , ,

Delay in diagnosis of menopause-like condition in young women linked to low bone density

21. June 2009 19:53
Women and young girls who experience delays in diagnosing a premature, menopause-like condition face increased risk of low bone density, according to new research by scientists at the National Institutes of Health. A delay in diagnosing the condition, called primary ovarian insufficiency, may make women more susceptible to osteoporosis and fractures later in life, the researchers concluded. [More]

Posted in: Women's Health News

Tags: , , , ,

Taxol-carrying nanoparticles

17. June 2009 05:27
Dr. Manuel Perez has broad experience in the academic, research and corporate worlds, having worked at Harvard Medical School, conducted research at Boston University and worked for the Millipore Corporation in Bedford, Mass. Since he joined UCF, he has written numerous articles in prestigious journals such as Nature Materials, Nano Letters, Small, PLoS ONE and Angewandte Chemie. Credit: Jacque Brund Nanoparticles specially engineered by University of Central Florida Assistant Professor J. Manuel Perez and his colleagues could someday target and destroy tumors, sparing patients from toxic, whole-body chemotherapies. [More]

Posted in: Medical Science News

Tags: , , , , , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.